Market Overview

Tekmira Pharmaceuticals, Lakeland Industries Moving On Possible Ebola Case In California

Share:

Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR) and Lakeland Industries, Inc.'s (NASDAQ: LAKE) shares were on the move Thursday afternoon, reacting to the news of a patient being treated for possible Ebola symptoms in Sacramento County, California.

According to Dignity Health, the company that runs the first hospital that the patient attended, the patient is now being treated in the UC Davis Medical Center, which "is specifically equipped to care for patients suspected of having or diagnosed with Ebola as part of the public health department's preparedness plan."

Tekmira manufactures a therapeutic targeting the Ebola-Guinea virus. Shares were recently trading at $26.23, up 2.6 percent.

Lakeland was down about 1.4 percent, but saw a big spike up midday. The company manufactures and sells safety garments and accessories like disposable/limited use protective clothing, high-end chemical protective suits and reusable woven garments.

Related Link: The Market Doesn't Fear Ebola: A Technical Look At Lakeland Industries

Both these stocks moved intensely during the last Ebola scare, peaking in the first half of October, before falling back in the second half of the month.

In heavy trading, both stocks were reaching about half their 30-day average trading volume by 2:15 p.m. EST.

Posted-In: California Ebola Ebola-GuineaNews Intraday Update Movers

 

Related Articles (LAKE + TKMR)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Wedbush Reiterates On Alibaba, Expects Shares To Maintain A 'Premium Valuation'

Freddie Mac Is Selling $410 Million In Delinquent Loans